Correlation of response to stereotactic radiotherapy and immunotherapy with toxicity and predictions by differences in Treg population.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e14039
Abstract: e14039 Background: Combining stereotactic ablative radiotherapy (SABR) and anti-PD1 therapy may result in synergism but the response and toxicity rates has not been established. Biomarkers to predict clinical outcomes in this setting could improve patient… read more here.
Keywords: response; immunotherapy; toxicity; treg population ... See more keywords